Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries

BACKGROUND: For the first time in almost 50 years, there are new drugs available for the treatment of tuberculosis (TB), including bedaquiline (BDQ) and delamanid (DLM). The rate of introduction, however, has not kept pace with patient needs. It is estimated that as many as 23% of multidrug-resistan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Tuberc Lung Dis
Autores principales: Guglielmetti, L., Hewison, C., Avaliani, Z., Hughes, J., Kiria, N., Lomtadze, N., Ndjeka, N., Setkina, S., Shabangu, A., Sikhondze, W., Skrahina, A., Veziris, N., Furin, J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5664221/
https://ncbi.nlm.nih.gov/pubmed/28234080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.16.0493
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares